ERIC DOBMEIER - 10 Feb 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role: President, CEO, Director
Signature: /s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 10 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2022, 18:54:09 UTC
Previous filing: 02 Feb 2022
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KDNY	Common Stock	Options Exercise		+20,247	+11%		200,880	10 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KDNY	Restricted Stock Units (RSU)	Options Exercise	$0	-20,247	-33%	$0.000000	40,496	10 Feb 2022	Common Stock	20,247		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F3	The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date.